Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × OTHER × isoquercitrin × Clear all

Phase

Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1 Fatigue 1 Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 213 Radiotherapy 153 Carboplatin 133 pembrolizumab 132 Gemcitabine 125 Nivolumab 122 Paclitaxel 117 Cisplatin 102 fludarabine 101 Dexamethasone 96 Lenalidomide 91 Rituximab 89 Docetaxel 87 Bevacizumab 84 Capecitabine 83 Temozolomide 82 fludarabine phosphate 80 Oxaliplatin 76 Cytarabine 76 Irinotecan 70 Etoposide 69 Filgrastim 68 Melphalan 64 venetoclax 63 Peripheral Blood Stem Cell Transplantation 62 Doxorubicin 61 Fluorouracil 59 Everolimus 58 Radiosurgery 57 durvalumab 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡